BCL2 and Alzheimer disease: This study observed that sulforaphane may ameliorate AD by regulating 45 targets, especially TNF, INS, and BCL2, suggesting the importance of the effects of sulforaphane on neuroinflammation, insulin resistance, and apoptosis on AD pathogenesis.